You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: June 2, 2024

Litigation Details for Allergan USA, Inc. v. MSN Laboratories Private Ltd. (Fed. Cir. 2023)

✉ Email this page to a colleague

« Back to Dashboard

Allergan USA, Inc. v. MSN Laboratories Private Ltd. (Fed. Cir. 2023)

Docket	⤷ Sign Up	Date Filed	2023-10-18
Court	Court of Appeals for the Federal Circuit	Date Terminated
Cause		Assigned To
Jury Demand		Referred To
Patents	10,188,632; 7,741,356; 7,786,158; 8,344,007; 8,344,011; 8,609,709; 8,691,860; 8,772,325; 9,000,011; 9,115,091; 9,205,076; 9,364,489; 9,675,587; 9,700,542; 9,789,125
Link to Docket	External link to docket

Small Molecule Drugs cited in Allergan USA, Inc. v. MSN Laboratories Private Ltd.

The small molecule drugs covered by the patents cited in this case are ⤷ Sign Up and ⤷ Sign Up .

Biologic Drugs cited in Allergan USA, Inc. v. MSN Laboratories Private Ltd.

The biologic drugs covered by the patents cited in this case are ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , and ⤷ Sign Up .

Details for Allergan USA, Inc. v. MSN Laboratories Private Ltd. (Fed. Cir. 2023)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
2023-12-28	17		)(IV) for U.S. Patent Nos. 9,675,587 (the '" 587 patent") and 10,188,632 (the "'… 10,188,632 B2 1/2019 Costello et al. …588,304, filed on May 5, 2017, now Pat. No. 10,188,632, which is a continuation of …associated with altered bowel habits (Drossman D 10,188,632, granted on Jan. 29, 2019; which is a continua… 10,188,632 B2 1/2019 Costello et al. (22)	External link to document
2024-01-29	19		231) ’626 patent U.S. Patent No. 6,452,626 ’632 patent U.S. Patent No. 10,188,632 (Appx48-72…earlier patents in the same family: U.S. Patent Nos. 9,675,587 (the “’587 patent”) and 10,188,632 (the …ABBREVIATIONS ’011 patent U.S. Patent No. 8,344,011 ’036 patent U.S. Patent No. 6,862,036 ’… ’179 patent U.S. Patent No. 11,007,179 (Appx73-101) ’356 patent U.S. Patent No. 7,741,356…14485) ’516 patent U.S. Patent No. 11,311,516 (Appx183-209) ’587 patent U.S. Patent No. 9,675,587	External link to document
2024-02-20	21		ABBREVIATIONS ’356 patent U.S. Patent No. 7,741,356 (Appx14407-14485) ’011 patent U.S.…U.S. Patent No. 8,344,011 ’709 patent U.S. Patent No. 8,609,709 ’516 patent U.S. Patent…the ’375 patent was not a proper reference patent for the ’483 patent because the ’375 patent issued later…original patent monopoly period, and that later-filed, later-expiring patents with patentably indistinct… filed patent is not a proper ODP reference patent for the first-filed, first-issued patent in the family	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.